Bryostatin-1 – Patient Worthy

source: pixabay.com

First Patient with Alzheimer’s Dosed in Bryostatin-1 Clinical Trial

Post author:Jessica Lynn
Post published:October 15, 2020
Post category:Alzheimer's disease without Neurofibrillary tangles

Last week, clinical stage biopharmaceutical company Neurotrope announced that the first patient was dosed in a Phase 2 clinical trial to test the safety, efficacy, and tolerability of bryostatin-1…

We believe rare disease patients are people, not a diagnosis. Through education, awareness and some humor, we help patients, caregivers and support persons by providing relevant and often inspirational news and stories.

Our goals are to share stories, cultivate strong community, provide the latest medical findings, connect people and pioneer production of patient worthy information. Help us attain these goals by telling us a little bit about yourself!

Let’s Work Together!

Keep Up to Date

Learn More